These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 2049248)

  • 1. Caffeine renal clearance and urine caffeine concentrations during steady state dosing. Implications for monitoring caffeine intake during sports events.
    Birkett DJ; Miners JO
    Br J Clin Pharmacol; 1991 Apr; 31(4):405-8. PubMed ID: 2049248
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship between urine flow rate and renal clearance of caffeine in man.
    Blanchard J; Sawers SJ
    J Clin Pharmacol; 1983 Apr; 23(4):134-8. PubMed ID: 6863577
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diurnal effect on caffeine clearance.
    Hashiguchi M; Fujimura A; Ohashi K; Ebihara A
    J Clin Pharmacol; 1992 Feb; 32(2):184-7. PubMed ID: 1613129
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Caffeine as a probe for CYP1A2 activity: potential influence of renal factors on urinary phenotypic trait measurements.
    Tang BK; Zhou Y; Kadar D; Kalow W
    Pharmacogenetics; 1994 Jun; 4(3):117-24. PubMed ID: 7920691
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship between total body clearance of caffeine and urine flow rate in elderly men.
    Trang JM; Blanchard J; Conrad KA; Harrison GG
    Biopharm Drug Dispos; 1985; 6(1):51-6. PubMed ID: 3986300
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Caffeine in sport. Urinary excretion of caffeine in healthy volunteers after intake of common caffeine-containing beverages.
    van der Merwe PJ; Müller FR; Müller FO
    S Afr Med J; 1988 Aug; 74(4):163-4. PubMed ID: 3406872
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vancomycin pharmacokinetics, renal handling, and nonrenal clearances in normal human subjects.
    Golper TA; Noonan HM; Elzinga L; Gilbert D; Brummett R; Anderson JL; Bennett WM
    Clin Pharmacol Ther; 1988 May; 43(5):565-70. PubMed ID: 3365918
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The influence of renal function on the renal clearance of morphine and its glucuronide metabolites in intensive-care patients.
    Milne RW; Nation RL; Somogyi AA; Bochner F; Griggs WM
    Br J Clin Pharmacol; 1992 Jul; 34(1):53-9. PubMed ID: 1633068
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of quinolones on caffeine disposition.
    Carbó M; Segura J; De la Torre R; Badenas JM; Camí J
    Clin Pharmacol Ther; 1989 Mar; 45(3):234-40. PubMed ID: 2920498
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Urinary caffeine after coffee consumption and heat dehydration.
    Chambaz A; Meirim I; Décombaz J
    Int J Sports Med; 2001 Jul; 22(5):366-72. PubMed ID: 11510874
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dose-dependency of caffeine metabolism with repeated dosing.
    Denaro CP; Brown CR; Wilson M; Jacob P; Benowitz NL
    Clin Pharmacol Ther; 1990 Sep; 48(3):277-85. PubMed ID: 2401126
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urine Caffeine Concentration in Doping Control Samples from 2004 to 2015.
    Aguilar-Navarro M; Muñoz G; Salinero JJ; Muñoz-Guerra J; Fernández-Álvarez M; Plata MDM; Del Coso J
    Nutrients; 2019 Jan; 11(2):. PubMed ID: 30699902
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Validation of urine caffeine metabolite ratios with use of stable isotope-labeled caffeine clearance.
    Denaro CP; Wilson M; Jacob P; Benowitz NL
    Clin Pharmacol Ther; 1996 Mar; 59(3):284-96. PubMed ID: 8653991
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The pharmacokinetics, metabolism and urinary detection time of caffeine in camels.
    Wasfi IA; Boni NS; Elghazali M; Abdel Hadi AA; Almuhrami AM; Barezaig IM; Alkatheeri NA
    Res Vet Sci; 2000 Aug; 69(1):69-74. PubMed ID: 10924397
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High correlation between clearance of renal protein-bound uremic toxins (indoxyl sulfate and p-cresyl sulfate) and renal water-soluble toxins in peritoneal dialysis patients.
    Huang WH; Hung CC; Yang CW; Huang JY
    Ther Apher Dial; 2012 Aug; 16(4):361-7. PubMed ID: 22817125
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of caffeine use in elite athletes following its removal from the World Anti-Doping Agency list of banned substances.
    Del Coso J; Muñoz G; Muñoz-Guerra J
    Appl Physiol Nutr Metab; 2011 Aug; 36(4):555-61. PubMed ID: 21854160
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Towards Further Verification of Physiologically-Based Kidney Models: Predictability of the Effects of Urine-Flow and Urine-pH on Renal Clearance.
    Matsuzaki T; Scotcher D; Darwich AS; Galetin A; Rostami-Hodjegan A
    J Pharmacol Exp Ther; 2019 Feb; 368(2):157-168. PubMed ID: 30413628
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma clearance rates and renal clearance of 3H-labeled cyclic AMP and 3H-labeled cyclic GMP in the dog.
    Blonde L; Wehmann RE; Steiner AL
    J Clin Invest; 1974 Jan; 53(1):163-72. PubMed ID: 4357610
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics of intravenously administered caffeine in healthy alpacas (Lama pacos) and llamas (Lama glama).
    Lakritz J; Middleton JR; Anderson DE; Linden DR; Sams RA; Tessman RK; Tyler JW
    Am J Vet Res; 2006 Jun; 67(6):1063-9. PubMed ID: 16740103
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The influence of caffeine on the steady-state pharmacokinetics of theophylline.
    Jonkman JH; Sollie FA; Sauter R; Steinijans VW
    Clin Pharmacol Ther; 1991 Mar; 49(3):248-55. PubMed ID: 2007319
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.